Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Biotech Leader ImmunoGen Eyes Early Buy Point Amid Path To Profitability

Among the best stocks to buy and watch, ovarian cancer treatment leader ImmunoGen is approaching an early buy point in today's stock market.

Investors Business Daily

The Unexpected Depression Drug News That Sent Xenon Pharmaceuticals Soaring

Biotech stock Xenon rocketed Monday, after its experimental epilepsy drug unexpectedly showed promise in depression treatment.

Investors Business Daily

NCA questions Matt Hancock and Michael Gove in PPE Medpro inquiry

Witness interviews conducted as part of corruption investigation into company linked to Tory peer Michelle Mone

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Catalent (CTLT) Loses 6.1% Over the Past Month: Can the Stock Reverse Its Fortune?

Catalent, Inc. (CTLT) recently faced a setback, witnessing a 6.1% dip in its stock value over the last month. However, in the light of the recent release of its first quarter results of fiscal 2024, can the company reverse its fortune? Keep reading….

StockNews.com

3 Biotech Stocks Bursting With Investment Potential

The biotech industry is well-positioned for robust growth thanks to the increasing demand for effective treatments for chronic diseases and the need to serve an aging population. To capitalize on the favorable industry trends, investing in quality biotech stocks Organogenesis Holdings (ORGO), Genmab A/S (GMAB), and Incyte (INCY) could be…

StockNews.com

3 Safe Biotech Stocks to Buy This Week

Given enhanced healthcare spending, the growing frequency of chronic diseases, government support, and rapid digital transformation, the biotech industry appears to have favorable prospects. Therefore, fundamentally strong biotech stocks Vertex Pharmaceuticals (VRTX), Innoviva (INVA), and Acorda Therapeutics, Inc. (ACOR) could be ideal additions to your portfolio this week. Read more….

StockNews.com

3 Biotech Stocks to Buy to Help the Health of Your Portfolio

Amid the dynamic biotech landscape, the sector is set to witness substantial growth fueled by multiple advancements. Hence, fundamentally strong biotech stocks ANI Pharmaceuticals (ANIP), Exelixis (EXEL), and Entrada Therapeutics (TRDA) might be solid investments now. Read more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

These Stocks Are Exploding In The November Stock Market Rally

The November rally continues with more names joining in. These five stock have outperformed with gains as high as 85% in November.

Investors Business Daily

OSHA finds plant explosion that killed 1 person could have been prevented

The federal Occupational Safety and Health Administration has found an explosion that killed one worker at a pharmaceutical chemical plant in Massachusetts could have been prevented

The Independent UK

Poor people in the developing world have a right to medicine

People should not die because of their income or where they were born. We must have the courage to stand up to the pharmaceutical industry

The Guardian - US

Under $15 Bargains: 3 Pharma Stocks to Watch

The pharmaceutical industry is anticipated to remain resilient, owing to increasing healthcare expenditure. Given this backdrop, it could be wise to watch quality pharma stocks Organon & Co. (OGN), GoodRx Holdings (GDRX), and Viatris (VTRS) trading under $15 now. Read on….

StockNews.com

Indian manufacturer recalls eyedrops previously cited in FDA warning

The Indian manufacturer of more than a number of eyedrops subject to a U.S. safety warning has officially recalled the products

The Independent UK

3 Biotech Stocks Beating BioMarin Pharmaceutical (BMRN)

Breakthrough developments, the use of advanced technologies, and rising investments in R&D are some of the factors driving the growth of the biotech industry. Although BioMarin Pharmaceutical (BMRN) showcases strong growth prospects, investors could consider buying even better biotech stocks Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and Vertex Pharmaceuticals (VRTX). Read…

StockNews.com

Lincoln Park life sciences hub adds 4 biotech research firms

The new tenants will bring the building at 2430 N. Halsted St. to 80% occupancy.

Chicago Sun-Times

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Analyzing Pharma Stock Giants: JNJ, MRK, and ABBV

The pharmaceutical industry is set for long-term growth due to growing demand for quality drugs and therapies, an aging population, and the rise in lifestyle-related diseases. Now, let's explore the investment potential of industry giants Merck & Co (MRK), Johnson & Johnson (JNJ), and AbbVie (ABBV). Keep reading.

Investors Business Daily

Arcellx, A Top 2% Stock, Breaks Out After Inking A $285 Million Deal With Gilead

Arcellx and Gilead's Kite division deepened their collaboration in cancer treatments on Wednesday. ACLX stock rocketed into a breakout.

Investors Business Daily

Azenta Surges, Nearing Breakout, After Ducking Out Of A Looming Proxy Fight

AZTA stock jumped early Tuesday on strong earnings and after saying an activist investor won't push for any more seats this year.

StockNews.com

Vertex Pharmaceuticals (VRTX) Post-Earnings Analysis: Is It Time to Buy the Stock?

After a solid third-quarter earnings report, does Vertex Pharmaceuticals (VRTX) deserve a place in your portfolio? Let’s look at its financial metrics to gauge its prospects….

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Amylyx Crashes 32% On A Quarterly Report That Doesn't Bode Well For 2024

Amylyx missed Wall Street's expectations on Thursday amid struggles for its amyotrophic lateral sclerosis drug, and AMLX stock crashed.

Investors Business Daily

This Health Care Play Breaks Out After Doubling The Market's Gains

MEDP stock has broken out of a cup with handle and has climbed 29% this year. Medpace offers clinical trial and medical device support.

StockNews.com

Becton Dickinson & Co. (BDX) Earnings Moves: A Buy or Sell for Investors?

Becton Dickinson & Co. (BDX) is expected to report steady growth for its fiscal fourth quarter ended September 2023, scheduled to be released on November 9. While the stock is witnessing weakness over the past month, will the quarterly report be able to spur a rally? Read on.

Investors Business Daily

Gilead Tumbles After An Unpredictable Element Drove Its Third-Quarter Beat

Investors hammered GILD stock on Wednesday after Gilead beat third-quarter expectations on the back of its Covid treatment, Veklury.

Investors Business Daily

BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake

Activist investor Elliott has reportedly built a $1 billion stake in BioMarin Pharmaceutical, Reuters reported Tuesday as BMRN stock rocketed.

StockNews.com

Biogen (BIIB) Earnings Spotlight: Is the Biotech Stock a Buy or Sell?

Biotech major Biogen (BIIB) will report its third-quarter results on November 8. Its EPS and revenue are expected to decline year-over-year. However, the FDA approvals for new drugs received by the company this year will likely support its long-term growth. Let’s discuss the potential road ahead for the stock….

StockNews.com

Gilead Sciences (GILD) Earnings Forecast and Gameplan

Gilead Sciences (GILD) boasts an impressive product portfolio and has surpassed the consensus estimate on the topline in each of the trailing four quarters. With the company gearing up to post its third quarter results, is GILD a wise investment now? Read on.

1 … 20 21 22 23

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.